Integral Health Asset Management, LLC

$2.1B reported 13(f) long value · latest quarter 2026-03-31 · CIK 1773206 · EDGAR ↗

sum of disclosed values for 2026-03-31; 0 positions carry a NULL value and are excluded from the sum, surfaced here rather than folded away: $2.1B
ALL retained default holdings for this (filer, period), including NULL-value ones: 90
positions with no comparable holding in the prior quarter (kind new), 2026-03-31: 30
positions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record: 26

A quarter-end snapshot. Filed up to 45 days later, so this page is not current holdings and never a complete portfolio. what a 13F is — and is not ↓ methodology §13F ↗

Position changes — into 2026-03-31

by shares · Δ value · filing link · how changes are classified §

Position changes into quarter 2026-03-31
position matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match `identity_reconciled_by_cusip`	the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE `classified_by_value` · EXIT = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · NO CHANGE = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an ADD or a TRIM (NEW / ADD / TRIM / EXIT / NO CHANGE) · NO PRIOR = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake	derived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero	reported unit changed across the pair (SH↔PRN); the share delta is withheld rather than fabricated `shares_unit_mismatch`	Prev value	Curr value	Prev shares	Curr shares
position key `pos:14207` · issuer key `iss:973` COM PAR $.01	ADD	+$27.7M	+250,000	$218M	$245M	1,250,000	1,500,000
position key `pos:14656` · issuer key `iss:1552` COM	ADD	+$50.3M	+300,000	$95.6M	$146M	1,200,000	1,500,000
position key `pos:12465` · issuer key `iss:548` COM NEW	ADD	+$16.5M	+200,000	$89.0M	$105M	1,400,000	1,600,000
position key `pos:14656` · issuer key `iss:1552` COM PUT	NEW	+$72.9M	+750,000	$0	$72.9M	—	750,000
position key `pos:12465` · issuer key `iss:548` COM NEW CALL	ADD	+$34.1M	+500,000	$31.8M	$65.9M	500,000	1,000,000
position key `pos:15140` · issuer key `iss:1537` COM	TRIM	−$15.4M	−20,000	$81.0M	$65.7M	105,000	85,000
position key `sid:sec:prov:c6f0567aff349dfe2dab4a6ee5ba8988` · issuer key `cusip6:92337R` CL A	TRIM	−$26.8M	−200,000	$91.2M	$64.4M	1,800,000	1,600,000
position key `pos:15318` · issuer key `iss:392` COM	ADD	+$16.0M	+70,000	$41.1M	$57.1M	200,000	270,000
position key `pos:17657` · issuer key `iss:2200` SHS	ADD	+$37.0M	+1,150,000	$18.4M	$55.4M	850,000	2,000,000
position key `pos:18251` · issuer key `iss:315` COM	ADD	+$25.2M	+500,000	$28.1M	$53.3M	750,000	1,250,000
position key `pos:16702` · issuer key `iss:1556` COM	ADD	+$1.3M	+125,000	$50.8M	$52.2M	475,000	600,000
position key `pos:17751` · issuer key `iss:1214` COM	ADD	+$24.8M	+175,000	$26.3M	$51.1M	250,000	425,000
position key `pos:11808` · issuer key `iss:635` COM	ADD	+$13.2M	+100,000	$37.2M	$50.4M	1,500,000	1,600,000
position key `pos:17695` · issuer key `iss:2037` ORD	NEW	+$49.3M	+250,000	$0	$49.3M	—	250,000
position key `pos:14656` · issuer key `iss:1552` COM CALL	NEW	+$48.6M	+500,000	$0	$48.6M	—	500,000
position key `pos:12603` · issuer key `iss:74` COM	ADD	+$1.9M	+375,000	$43.5M	$45.4M	2,200,000	2,575,000
position key `pos:14095` · issuer key `iss:307` COM	ADD	+$13.1M	+325,000	$21.5M	$34.5M	225,000	550,000
position key `pos:15121` · issuer key `iss:1122` COM	ADD	+$6.3M	+1,300,000	$21.1M	$27.4M	3,000,000	4,300,000
position key `pos:15965` · issuer key `iss:175` SPONSORED ADR	ADD	+$7.1M	+25,000	$19.2M	$26.3M	90,000	115,000
position key `pos:17712` · issuer key `iss:1630` COM	ADD	+$11.4M	+200,000	$13.2M	$24.6M	300,000	500,000
position key `pos:15047` · issuer key `iss:135` COM	ADD	+$923K	+15,000	$21.0M	$22.0M	60,000	75,000
position key `pos:14584` · issuer key `iss:311` COM	NEW	+$20.4M	+275,000	$0	$20.4M	—	275,000
position key `pos:15808` · issuer key `iss:825` COM	TRIM	−$17.9M	−150,000	$36.7M	$18.8M	325,000	175,000
position key `pos:15725` · issuer key `iss:172` COM	ADD	+$12.2M	+200,000	$6.6M	$18.8M	100,000	300,000
position key `pos:10586` · issuer key `iss:1908` COM	NEW	+$17.9M	+40,000	$0	$17.9M	—	40,000
position key `pos:10700` · issuer key `iss:1374` COM	ADD	+$7.9M	+200,000	$9.8M	$17.7M	1,200,000	1,400,000
position key `pos:16159` · issuer key `iss:94` COM	NEW	+$17.6M	+800,000	$0	$17.6M	—	800,000
position key `sid:sec:prov:a6f31b4733de62bae5fced1fb39b0119` · issuer key `cusip6:358029` SPONSORED ADR	ADD	+$2.0M	+125,000	$15.5M	$17.5M	650,000	775,000
position key `pos:16805` · issuer key `iss:997` COM NEW	TRIM	−$46.2M	−75,000	$62.3M	$16.1M	110,000	35,000
position key `pos:10600` · issuer key `iss:821` COM	NEW	+$13.9M	+100,000	$0	$13.9M	—	100,000
position key `pos:15863` · issuer key `iss:1123` COM	TRIM	−$7.7M	−5,000	$21.5M	$13.8M	20,000	15,000
position key `pos:16440` · issuer key `iss:637` COM	TRIM	−$14.1M	−155,000	$27.7M	$13.6M	325,000	170,000
position key `sid:sec:prov:d00159df48fd34cc806ae902a076ba0a` · issuer key `cusip6:603170` COM CALL	ADD	+$4.5M	+250,000	$9.1M	$13.5M	250,000	500,000
position key `pos:17421` · issuer key `iss:475` COM	NEW	+$13.5M	+350,000	$0	$13.5M	—	350,000
position key `pos:15395` · issuer key `iss:638` COM	ADD	+$7.5M	+300,000	$5.7M	$13.2M	250,000	550,000
position key `pos:14357` · issuer key `iss:1170` COM	NEW	+$13.1M	+25,000	$0	$13.1M	—	25,000
position key `pos:17547` · issuer key `iss:577` COM	TRIM	+$1.3M	−125,000	$11.3M	$12.6M	275,000	150,000
position key `sid:sec:prov:e7743277455b5823374498b009dffbbe` · issuer key `cusip6:75901B` COM	ADD	−$4.7M	+300,000	$17.3M	$12.6M	1,200,000	1,500,000
position key `pos:12433` · issuer key `iss:1513` COM	TRIM	−$1.3M	−15,000	$13.0M	$11.8M	75,000	60,000
position key `pos:12517` · issuer key `iss:1997` COM	NEW	+$11.6M	+200,000	$0	$11.6M	—	200,000
position key `pos:11747` · issuer key `iss:680` COM	NEW	+$11.3M	+700,000	$0	$11.3M	—	700,000
position key `sid:sec:prov:d8f1dce881f876173d775baaae476159` · issuer key `cusip6:02157Q` COM SHS	ADD	+$4.6M	+125,000	$6.7M	$11.2M	375,000	500,000
position key `pos:11450` · issuer key `iss:267` COM	TRIM	−$6.6M	−40,000	$17.6M	$11.0M	100,000	60,000
position key `pos:15034` · issuer key `iss:573` COM	TRIM	−$22.2M	−325,000	$33.2M	$11.0M	500,000	175,000
position key `pos:12161` · issuer key `iss:587` COM	NEW	+$10.9M	+170,000	$0	$10.9M	—	170,000
position key `sid:sec:prov:48ac0f50c981e01f7c5af17d58a117cf` · issuer key `cusip6:67080M` COM	ADD	+$5.2M	+400,000	$5.7M	$10.9M	300,000	700,000
position key `pos:13354` · issuer key `iss:367` COM	TRIM	−$28.9M	−350,000	$39.7M	$10.8M	500,000	150,000
position key `pos:17009` · issuer key `iss:510` COM	TRIM	−$15.9M	−175,000	$26.6M	$10.7M	325,000	150,000
position key `pos:15125` · issuer key `iss:1798` COM	NEW	+$9.8M	+20,000	$0	$9.8M	—	20,000
position key `pos:10996` · issuer key `iss:2155` SHS	NEW	+$9.5M	+150,000	$0	$9.5M	—	150,000
position key `pos:13781` · issuer key `iss:1096` COM	ADD	+$2.8M	+25,000	$6.7M	$9.5M	100,000	125,000
position key `pos:11535` · issuer key `iss:1757` COM	ADD	+$7.6M	+250,000	$1.8M	$9.4M	200,000	450,000
position key `pos:11517` · issuer key `iss:1003` COM	NEW	+$9.4M	+125,000	$0	$9.4M	—	125,000
position key `sid:sec:prov:7ff2ed7cd5581a47f16a78be72caca7a` · issuer key `cusip6:799566` COM	ADD	−$3.0M	+200,000	$12.2M	$9.2M	3,000,000	3,200,000
position key `sid:sec:prov:f702a4fd275ccf1ac7ea45ff5986f07c` · issuer key `cusip6:74365U` COM STK	TRIM	−$2.9M	−500,000	$12.0M	$9.1M	2,250,000	1,750,000
position key `pos:11663` · issuer key `iss:670` COM	TRIM	−$2.0M	−150,000	$10.9M	$8.9M	500,000	350,000
position key `pos:13686` · issuer key `iss:2049` COM	TRIM	−$8.5M	−500,000	$16.9M	$8.5M	1,500,000	1,000,000
position key `sid:sec:prov:eb359106a5c4d721cdc955ced4da0795` · issuer key `cusip6:87164F` COM	ADD	+$4.0M	+150,000	$4.2M	$8.2M	200,000	350,000
position key `pos:16822` · issuer key `iss:1916` COM	ADD	+$4.6M	+150,000	$3.5M	$8.1M	100,000	250,000
position key `pos:16675` · issuer key `iss:563` COM SHS	NEW	+$7.6M	+400,000	$0	$7.6M	—	400,000
position key `sid:sec:prov:fbdfb263adbfc86bd605b695db4205d4` · issuer key `cusip6:07373V` COM	TRIM	−$8.1M	−250,000	$15.2M	$7.1M	550,000	300,000
position key `sid:sec:prov:f5ab5fc62f8ffc42012ac685dc8651c0` · issuer key `cusip6:14070B` COM NEW	NEW	+$6.1M	+200,000	$0	$6.1M	—	200,000
position key `pos:16495` · issuer key `iss:1005` COM	NEW	+$6.0M	+35,000	$0	$6.0M	—	35,000
position key `pos:13067` · issuer key `iss:210` COM	NEW	+$5.9M	+35,000	$0	$5.9M	—	35,000
position key `pos:13950` · issuer key `iss:1497` COM	NEW	+$5.3M	+50,000	$0	$5.3M	—	50,000
position key `sid:sec:prov:adbff6ad799c41f5a1fe4cddc6ffc42b` · issuer key `cusip6:30054Y` COM SHS	ADD	+$3.0M	+100,000	$2.1M	$5.2M	125,000	225,000
position key `pos:12414` · issuer key `iss:29` COM	NEW	+$4.7M	+200,000	$0	$4.7M	—	200,000
position key `pos:12417` · issuer key `iss:2008` COM	NEW	+$4.5M	+50,000	$0	$4.5M	—	50,000
position key `sid:sec:prov:fcb734c2b01cb725ac58cb009a803c4c` · issuer key `cusip6:34962G` COM NEW	NEW	+$3.9M	+150,000	$0	$3.9M	—	150,000
position key `sid:sec:prov:be515631054470e2500985b7cc1d1245` · issuer key `cusip6:50180M` COM SHS	ADD	+$1.5M	+50,000	$2.2M	$3.7M	100,000	150,000
position key `sid:sec:prov:2bc6a25d40cf07124e3a03bdecf4a4df` · issuer key `cusip6:805111` COM	NEW	+$3.3M	+600,000	$0	$3.3M	—	600,000
position key `sid:sec:prov:0492e747c8d37a4dab1ade9330576c2c` · issuer key `cusip6:75955J` COM	NEW	+$3.1M	+450,000	$0	$3.1M	—	450,000
position key `pos:15541` · issuer key `iss:958` ADS	NEW	+$3.0M	+100,000	$0	$3.0M	—	100,000
position key `sid:sec:prov:8cb65945c1d745d32abfa3ce25a4d2e9` · issuer key `cusip6:45719W` COM NEW	TRIM	−$1.3M	−400,000	$3.6M	$2.3M	1,750,000	1,350,000
position key `pos:13935` · issuer key `iss:1355` COM	NEW	+$2.2M	+150,000	$0	$2.2M	—	150,000
position key `sid:sec:prov:36f6260da0bf69546f0e601e6d5bafdc` · issuer key `cusip6:46124U` ADS	NEW	+$2.2M	+400,000	$0	$2.2M	—	400,000
position key `pos:10212` · issuer key `iss:1665` COM	NEW	+$2.0M	+50,000	$0	$2.0M	—	50,000
position key `sid:sec:prov:dfd0154b493c84f8cf2ed4d228add022` · issuer key `cusip6:90466Y` COM NEW	NEW	+$1.5M	+225,000	$0	$1.5M	—	225,000
pos:10385	EXIT‡e	−$31.1M	−100,000	$31.1M	$0	100,000	—
pos:11138	EXIT‡e	−$14.3M	−200,000	$14.3M	$0	200,000	—
pos:11955	EXIT‡e	−$5.9M	−125,000	$5.9M	$0	125,000	—
pos:12344	EXIT‡e	−$23.1M	−130,000	$23.1M	$0	130,000	—
pos:13406	EXIT‡e	−$64.8M	−675,000	$64.8M	$0	675,000	—
pos:13569	EXIT‡e	−$6.9M	−75,000	$6.9M	$0	75,000	—
pos:14470	EXIT‡e	−$2.9M	−200,000	$2.9M	$0	200,000	—
pos:14866	EXIT‡e	−$31.2M	−1,000,000	$31.2M	$0	1,000,000	—
pos:15075	EXIT‡e	−$1.6M	−200,000	$1.6M	$0	200,000	—
pos:15131	EXIT‡e	−$23.9M	−60,000	$23.9M	$0	60,000	—
pos:16115	EXIT‡e	−$16.5M	−50,000	$16.5M	$0	50,000	—
pos:16187	EXIT‡e	−$30.5M	−250,000	$30.5M	$0	250,000	—
pos:16949	EXIT‡e	−$9.0M	−45,000	$9.0M	$0	45,000	—
pos:17130	EXIT‡e	−$19.9M	−100,000	$19.9M	$0	100,000	—
pos:17136	EXIT‡e	−$17.7M	−400,000	$17.7M	$0	400,000	—
pos:17319	EXIT‡e	−$10.6M	−100,000	$10.6M	$0	100,000	—
pos:17454	EXIT‡e	−$32.2M	−350,000	$32.2M	$0	350,000	—
pos:17472	EXIT‡e	−$17.2M	−425,000	$17.2M	$0	425,000	—
sid:sec:prov:08b4ddd7740553d5019530b2d4dd293b	EXIT‡e	−$3.4M	−425,000	$3.4M	$0	425,000	—
sid:sec:prov:1e348df3cde91ba41d5ebeef0c53e107	EXIT‡e	−$20.4M	−750,000	$20.4M	$0	750,000	—
sid:sec:prov:233302be8852a126d4f3dc726082a4c4	EXIT‡e	−$5.0M	−200,000	$5.0M	$0	200,000	—
sid:sec:prov:3044f98940a2897deb445091c04637d0	EXIT‡e	−$4.7M	−350,000	$4.7M	$0	350,000	—

Flags: no row carries a flag.

1–20 of the 100 changes on this page

Mark-to-market only (no share change) · 12

Positions whose share count is identical in both quarters; the value changed with price, not with a decision.

Positions held with no share change into quarter 2026-03-31
position matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match `identity_reconciled_by_cusip`	the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE `classified_by_value` · EXIT = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · NO CHANGE = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an ADD or a TRIM (NEW / ADD / TRIM / EXIT / NO CHANGE) · NO PRIOR = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake	derived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero	Prev value	Curr value	Prev shares	Curr shares
position key `pos:14360` · issuer key `iss:1327` SPONSORED ADR	NO CHANGE	+$3.7M	$34.5M	$38.2M	250,000	250,000
position key `pos:12687` · issuer key `iss:419` COM	NO CHANGE	−$5.5M	$26.7M	$21.3M	650,000	650,000
position key `sid:sec:prov:d00159df48fd34cc806ae902a076ba0a` · issuer key `cusip6:603170` COM	NO CHANGE	−$6.9M	$27.2M	$20.3M	750,000	750,000
position key `pos:11462` · issuer key `iss:1296` COM	NO CHANGE	−$1.5M	$21.3M	$19.8M	150,000	150,000
position key `pos:11075` · issuer key `iss:2299` SHS	NO CHANGE	−$6.8M	$21.5M	$14.7M	900,000	900,000
position key `pos:10610` · issuer key `iss:1761` COM	NO CHANGE	−$2.3M	$16.4M	$14.0M	200,000	200,000
position key `pos:11142` · issuer key `iss:1475` COM NEW	NO CHANGE	+$1.1M	$11.8M	$12.9M	40,000	40,000
position key `sid:sec:prov:9c654c0b85e21e330a7ebfd2ced217c7` · issuer key `cusip6:834203` COM	NO CHANGE	−$4.2M	$15.0M	$10.9M	325,000	325,000
position key `pos:10390` · issuer key `iss:416` COM	NO CHANGE	+$1.2M	$8.0M	$9.1M	80,000	80,000
position key `sid:sec:prov:cb2ee571f458a0a64c1c152656def847` · issuer key `cusip6:76200L` COM NEW	NO CHANGE	+$1.4M	$4.7M	$6.1M	2,000,000	2,000,000
position key `pos:15345` · issuer key `iss:1204` COM	NO CHANGE	−$1.2M	$4.1M	$3.0M	100,000	100,000
position key `sid:sec:prov:9e958f4e10d0d474cc9e75d42ea33a9a` · issuer key `cusip6:88032L` COM NEW	NO CHANGE	+$635K	$2.0M	$2.7M	167,000	167,000

Flags: no row carries a flag.

Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.

Truncated by Public Filings. Changes compare every position with a security identifier, new and exited included; holdings without one are counted, not compared. methodology §13F ↗

Reported positions — 2026-03-31

1–86 of 86 issuers · $2.1B disclosed value over 90 rows · 0 undisclosed-value rows

View

This build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.

This list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names.

a position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing

Share of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets.

value undisclosed on the filing: retained and counted, excluded from sums, never shown as $0

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

REVOLUTION MEDICINES INC

3 positions · 3 reported rows

Rows Integral Health Asset Management, LLC reported for REVOLUTION MEDICINES INC, as it reported them
REVOLUTION MEDICINES INC · COM CUSIP — src ↗	$146M	1,500,000
REVOLUTION MEDICINES INC · COM · PUT CUSIP — src ↗	$72.9M	750,000
REVOLUTION MEDICINES INC · COM · CALL CUSIP — src ↗	$48.6M	500,000

$267M

2,750,000

12.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

INSMED INC · COM PAR $.01 CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$245M

1,500,000

11.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

CYTOKINETICS INC

2 positions · 2 reported rows

Rows Integral Health Asset Management, LLC reported for CYTOKINETICS INC, as it reported them
CYTOKINETICS INC · COM NEW CUSIP — src ↗	$105M	1,600,000
CYTOKINETICS INC · COM NEW · CALL CUSIP — src ↗	$65.9M	1,000,000

$171M

2,600,000

8.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

REGENERON PHARMACEUTICALS · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$65.7M

85,000

3.1%

—

VERA THERAPEUTICS INC · CL A CUSIP 92337R101
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$64.4M

1,600,000

3.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

CARDINAL HEALTH INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$57.1M

270,000

2.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ROIVANT SCIENCES LTD · SHS CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$55.4M

2,000,000

2.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BRIGHTSPRING HEALTH SVCS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$53.3M

1,250,000

2.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

RHYTHM PHARMACEUTICALS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$52.2M

600,000

2.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

MERCK & CO INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$51.1M

425,000

2.4%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

EDGEWISE THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$50.4M

1,600,000

2.4%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ASTRAZENECA PLC · ORD CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$49.3M

250,000

2.4%

—

ALIGNMENT HEALTHCARE INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$45.4M

2,575,000

2.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

NOVARTIS AG · SPONSORED ADR CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$38.2M

250,000

1.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BOSTON SCIENTIFIC CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$34.5M

550,000

1.7%

—

MINERALYS THERAPEUTICS INC

2 positions · 2 reported rows

Rows Integral Health Asset Management, LLC reported for MINERALYS THERAPEUTICS INC, as it reported them
MINERALYS THERAPEUTICS INC · COM CUSIP 603170101 src ↗	$20.3M	750,000
MINERALYS THERAPEUTICS INC · COM · CALL CUSIP 603170101 src ↗	$13.5M	500,000

ticker not yet mapped

$33.9M

1,250,000

1.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

LIFESTANCE HEALTH GROUP INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$27.4M

4,300,000

1.3%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ASCENDIS PHARMA A/S · SPONSORED ADR CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$26.3M

115,000

1.3%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

SCHOLAR ROCK HLDG CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$24.6M

500,000

1.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ELEVANCE HEALTH INC FORMERLY · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$22.0M

75,000

1.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

CENTENE CORP DEL · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$21.3M

650,000

1.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BRIDGEBIO PHARMA INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$20.4M

275,000

1.0%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

NEUROCRINE BIOSCIENCES INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$19.8M

150,000

0.9%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

GLAUKOS CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$18.8M

175,000

0.9%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ARROWHEAD PHARMACEUTICALS IN · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$18.8M

300,000

0.9%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

VERTEX PHARMACEUTICALS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$17.9M

40,000

0.9%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ORIC PHARMACEUTICALS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$17.7M

1,400,000

0.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ALUMIS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$17.6M

800,000

0.8%

—

FRESENIUS MEDICAL CARE AG · SPONSORED ADR CUSIP 358029106
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$17.5M

775,000

0.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

INTUITIVE SURGICAL INC · COM NEW CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$16.1M

35,000

0.8%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

UNIQURE NV · SHS CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$14.7M

900,000

0.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

TARSUS PHARMACEUTICALS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$14.0M

200,000

0.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

GILEAD SCIENCES INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$13.9M

100,000

0.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ELI LILLY & CO · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$13.8M

15,000

0.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

EDWARDS LIFESCIENCES CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$13.6M

170,000

0.7%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

COGENT BIOSCIENCES INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$13.5M

350,000

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ELANCO ANIMAL HEALTH INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$13.2M

550,000

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

MADRIGAL PHARMACEUTICALS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$13.1M

25,000

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

PRAXIS PRECISION MEDICINES I · COM NEW CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$12.9M

40,000

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

DIANTHUS THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$12.6M

150,000

0.6%

—

REGENXBIO INC · COM CUSIP 75901B107
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$12.6M

1,500,000

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

QUEST DIAGNOSTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$11.8M

60,000

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

XENON PHARMACEUTICALS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$11.6M

200,000

0.6%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ERASCA INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$11.3M

700,000

0.5%

—

ALTO NEUROSCIENCE INC · COM SHS CUSIP 02157Q109
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$11.2M

500,000

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

BIOGEN INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$11.0M

60,000

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

DEXCOM INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$11.0M

175,000

0.5%

—

SOLENO THERAPEUTICS INC · COM CUSIP 834203309
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$10.9M

325,000

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

DISC MEDICINE INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$10.9M

170,000

0.5%

—

NURIX THERAPEUTICS INC · COM CUSIP 67080M103
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$10.9M

700,000

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

CVS HEALTH CORP · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$10.8M

150,000

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

COOPER COS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$10.7M

150,000

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

THERMO FISHER SCIENTIFIC INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$9.8M

20,000

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

LIVANOVA PLC · SHS CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$9.5M

150,000

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

LANTHEUS HLDGS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$9.5M

125,000

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

TANGO THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$9.4M

450,000

0.5%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

IONIS PHARMACEUTICALS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$9.4M

125,000

0.4%

—

SANA BIOTECHNOLOGY INC · COM CUSIP 799566104
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$9.2M

3,200,000

0.4%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

CELCUITY INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$9.1M

80,000

0.4%

—

PROTARA THERAPEUTICS INC · COM STK CUSIP 74365U107
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$9.1M

1,750,000

0.4%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ENVISTA HOLDINGS CORPORATION · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$8.9M

350,000

0.4%

—

BIOHAVEN LTD · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$8.5M

1,000,000

0.4%

—

SYNDAX PHARMACEUTICALS INC · COM CUSIP 87164F105
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$8.2M

350,000

0.4%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

VIKING THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$8.1M

250,000

0.4%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

DEFINIUM THERAPEUTICS INC · COM SHS CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$7.6M

400,000

0.4%

—

BEAM THERAPEUTICS INC · COM CUSIP 07373V105
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$7.1M

300,000

0.3%

—

REZOLUTE INC · COM NEW CUSIP 76200L309
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$6.1M

2,000,000

0.3%

—

CAPRICOR THERAPEUTICS INC · COM NEW CUSIP 14070B309
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$6.1M

200,000

0.3%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

IQVIA HLDGS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$6.0M

35,000

0.3%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

AXSOME THERAPEUTICS INC. · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$5.9M

35,000

0.3%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

PROTAGONIST THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$5.3M

50,000

0.3%

—

EVOMMUNE INC · COM SHS CUSIP 30054Y107
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$5.2M

225,000

0.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ACADIA HEALTHCARE COMPANY IN · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$4.7M

200,000

0.2%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

ZIMMER BIOMET HOLDINGS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$4.5M

50,000

0.2%

—

FORTE BIOSCIENCES INC · COM NEW CUSIP 34962G208
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$3.9M

150,000

0.2%

—

LB PHARMACEUTICALS INC · COM SHS CUSIP 50180M108
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$3.7M

150,000

0.2%

—

SAVARA INC · COM CUSIP 805111101
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$3.3M

600,000

0.2%

—

RELMADA THERAPEUTICS INC · COM CUSIP 75955J402
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$3.1M

450,000

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

IMMUNOCORE HLDGS PLC · ADS CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$3.0M

100,000

0.1%

—

MAZE THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$3.0M

100,000

0.1%

—

TENAX THERAPEUTICS INC · COM NEW CUSIP 88032L605
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$2.7M

167,000

0.1%

—

INHIBIKASE THERAPEUTICS INC · COM NEW CUSIP 45719W205
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$2.3M

1,350,000

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

OLEMA PHARMACEUTICALS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$2.2M

150,000

0.1%

—

INVENTIVA SA · ADS CUSIP 46124U107
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$2.2M

400,000

0.1%

verified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred)

SIONNA THERAPEUTICS INC · COM CUSIP —
2026-03-31 filed 2026-05-15 +45d

src ↗

$2.0M

50,000

0.1%

—

UNICYCIVE THERAPEUTICS INC · COM NEW CUSIP 90466Y202
2026-03-31 filed 2026-05-15 +45d

src ↗

ticker not yet mapped

$1.5M

225,000

0.1%

1–20 of 86 issuers

Change kind and share change are in Position changes above; Congress overlap is planned.

One line per issuer, largest first; a row with no issuer key stands on its own line. Open a line for its rows as this filer reported them. The list holds every row this filer reported for the quarter. Issuer totals on the holders pages count each manager's own report once; that never removes a row here. how positions are grouped ↗

Book shape

2026-03-31 · concentration · vs tracked median · tick = median

Top-25 concentration: 70.0%below median 80.0%
Concentration index: 339 bpsbelow median 446 bps
Positions with value: 90 / 90median book 97.5 positions

Concentration uses reported 13F long value, not total assets. The index is withheld when any position lacks a value. Medians are over the 8,748 tracked filers with a 2026-03-31 book; the index median over the 8,662 with a complete book.

holdings whose <value> did not parse — retained and counted, never zero-filled: 0 · share of the period's disclosed value held in the top-N positions; denominator is reported 13F value, not total assets: 70.0% · integer Herfindahl–Hirschman index in basis points over disclosed position values: 339 · QoQ moves: 116

Filing history

AVAILABLE QUARTERS

Available filing periods
Period	Source
2026-03-31	EDGAR ↗

PLANNED sector rotation · Congress overlap · signals for this filer

Complete source filings on SEC EDGAR

The complete filing on EDGAR.

The position list above is served from the published Public Filings build, each position as this filer reported it; where the page cannot embed every reported row, the list says how many it leaves out. This block is provenance, not a substitute: the filing itself is the record, and it is one click away. Public Filings decided on 2026-08-01 to serve this list from its published build; filings newer than this build are on EDGAR.

Open Integral Health Asset Management, LLC's 13F filings on SEC EDGAR ↗

Notes on this data

Reported positions

Quarter-end holdings as filed

Explore the full published position list and its source filing. This record excludes the manager’s cash, shorts and non-13(f) assets.

Share changes

Compare consecutive quarters

Position changes retain the producer’s classification and comparability flags. Share counts and reported values describe different changes.

Coverage

A snapshot, not current holdings

Use the quarter selector to inspect available periods. Unknown values stay unknown and each table states its coverage.

A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗

13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.

Positions are quarter-end snapshots filed up to 45 days late — not current holdings. A position may have been changed or closed before you ever see it, and is older still by however long ago that quarter ended.

Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars with unit_basis carried on every record.

Affiliated managers may report the same position (otherManager), so one position can appear under more than one filer.

Positions under confidential treatment may be omitted until a later amendment discloses them.

These are disclosures, not investment advice (ARCHITECTURE.md §5.2 / M2-CONTRACT §5).